Details for: BIN1

Gene ID: 274

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: BIN1

Ensembl ID: ENSG00000136717

Description: bridging integrator 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • muscle cell CL0000187
    CSI 25.2
    rCSI 51.74%
    PRS 67.11
  • myeloid leukocyte CL0000766
    CSI 19.83
    rCSI 18.3%
    PRS 45.8
  • fast muscle cell CL0000190
    CSI 17.84
    rCSI 69.71%
    PRS 55.51
  • Hofbauer cell CL3000001
    CSI 17.76
    rCSI 33.53%
    PRS 55.15
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 17.49
    rCSI 15.93%
    PRS 59.93
  • bronchus fibroblast of lung CL2000093
    CSI 17.47
    rCSI 14.19%
    PRS 45.53
  • OFF-bipolar cell CL0000750
    CSI 13.86
    rCSI 18.95%
    PRS 54.65
  • cerebellar granule cell CL0001031
    CSI 12.22
    rCSI 17.96%
    PRS 40.92
  • vascular associated smooth muscle cell CL0000359
    CSI 10.7
    rCSI 34.72%
    PRS 47.59
  • colon epithelial cell CL0011108
    CSI 10.31
    rCSI 10.8%
    PRS 42.15
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 9.03
    rCSI 8.87%
    PRS 60.25
  • transit amplifying cell CL0009010
    CSI 7.82
    rCSI 11.96%
    PRS 61.17
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 7.5
    rCSI 9.05%
    PRS 52.77
  • T follicular helper cell CL0002038
    CSI 6.77
    rCSI 5.07%
    PRS 59.39
  • B cell CL0000236
    CSI 5.96
    rCSI 7.97%
    PRS 73.8
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 5.88
    rCSI 4.13%
    PRS 66.9
  • mature B cell CL0000785
    CSI 5.75
    rCSI 5%
    PRS 54.34
  • sncg GABAergic cortical interneuron CL4023015
    CSI 5.73
    rCSI 9.21%
    PRS 31.64
  • immature B cell CL0000816
    CSI 5.7
    rCSI 4.24%
    PRS 58.09
  • astrocyte of the cerebral cortex CL0002605
    CSI 5.62
    rCSI 12.61%
    PRS 30.3
  • retinal bipolar neuron CL0000748
    CSI 5.5
    rCSI 10.3%
    PRS 34.99
  • macrophage CL0000235
    CSI 5.46
    rCSI 9.94%
    PRS 72.9
  • oligodendrocyte CL0000128
    CSI 5.39
    rCSI 15.94%
    PRS 35.46
  • myofibroblast cell CL0000186
    CSI 5.06
    rCSI 7.01%
    PRS 49.7
  • adventitial cell CL0002503
    CSI 4.98
    rCSI 11.89%
    PRS 55.43
  • ON-bipolar cell CL0000749
    CSI 4.95
    rCSI 7.36%
    PRS 47.46
  • dendritic cell, human CL0001056
    CSI 4.66
    rCSI 7.16%
    PRS 51.88
  • follicular B cell CL0000843
    CSI 4.63
    rCSI 16.84%
    PRS 77.62
  • double negative thymocyte CL0002489
    CSI 4.43
    rCSI 3.08%
    PRS 53.46
  • naive T cell CL0000898
    CSI 4.42
    rCSI 3.08%
    PRS 57.78
  • enteroendocrine cell CL0000164
    CSI 4.3
    rCSI 5.87%
    PRS 47.58
  • intermediate monocyte CL0002393
    CSI 4.29
    rCSI 6.48%
    PRS 46.92
  • mature microglial cell CL0002629
    CSI 4.25
    rCSI 17.65%
    PRS 45.86
  • common lymphoid progenitor CL0000051
    CSI 4.24
    rCSI 5.67%
    PRS 67.18
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 4.2
    rCSI 12.03%
    PRS 62.58
  • epithelial cell CL0000066
    CSI 4.1
    rCSI 6.3%
    PRS 46.88
  • microglial cell CL0000129
    CSI 4.04
    rCSI 16.26%
    PRS 55.19
  • elicited macrophage CL0000861
    CSI 4.03
    rCSI 3.7%
    PRS 52.28
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 4
    rCSI 2.36%
    PRS 60.03
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 4
    rCSI 3.93%
    PRS 71.66
  • glutamatergic neuron CL0000679
    CSI 3.94
    rCSI 8.09%
    PRS 39.42
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 3.81
    rCSI 2.74%
    PRS 57.83
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 3.73
    rCSI 13.44%
    PRS 28.49
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 3.73
    rCSI 3.45%
    PRS 64.89
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 3.67
    rCSI 2.94%
    PRS 66.23
  • GABAergic neuron CL0000617
    CSI 3.66
    rCSI 12.27%
    PRS 33.58
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 3.58
    rCSI 11.18%
    PRS 33.05
  • enteric smooth muscle cell CL0002504
    CSI 3.53
    rCSI 5.03%
    PRS 47.57
  • memory B cell CL0000787
    CSI 3.5
    rCSI 3.45%
    PRS 77.72
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 3.48
    rCSI 3.14%
    PRS 41.62
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 3.48
    rCSI 13.13%
    PRS 30.51
  • inhibitory interneuron CL0000498
    CSI 3.47
    rCSI 8.02%
    PRS 36.85
  • rod bipolar cell CL0000751
    CSI 3.46
    rCSI 6.22%
    PRS 38.48
  • precursor B cell CL0000817
    CSI 3.39
    rCSI 2.97%
    PRS 54.56
  • alveolar adventitial fibroblast CL4028006
    CSI 3.32
    rCSI 5.24%
    PRS 46.01
  • skin fibroblast CL0002620
    CSI 3.3
    rCSI 2.84%
    PRS 53.3
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 3.27
    rCSI 4.11%
    PRS 81.17
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 3.27
    rCSI 5.1%
    PRS 71.65
  • plasmablast CL0000980
    CSI 3.24
    rCSI 2.55%
    PRS 51.27
  • conventional dendritic cell CL0000990
    CSI 3.13
    rCSI 2.61%
    PRS 65.15
  • memory T cell CL0000813
    CSI 3.09
    rCSI 5.96%
    PRS 74.68
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.07
    rCSI 2.33%
    PRS 56.2
  • mature T cell CL0002419
    CSI 2.96
    rCSI 2.3%
    PRS 61.79
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 2.91
    rCSI 2.18%
    PRS 76.75
  • pancreatic D cell CL0000173
    CSI 2.84
    rCSI 2.79%
    PRS 47.28
  • retinal cone cell CL0000573
    CSI 2.77
    rCSI 4.47%
    PRS 35.85
  • class switched memory B cell CL0000972
    CSI 2.76
    rCSI 2.06%
    PRS 63.4
  • unswitched memory B cell CL0000970
    CSI 2.67
    rCSI 2.24%
    PRS 62.27
  • pro-B cell CL0000826
    CSI 2.64
    rCSI 2.19%
    PRS 45.85
  • IgG plasma cell CL0000985
    CSI 2.64
    rCSI 3.16%
    PRS 64.05
  • perivascular cell CL4033054
    CSI 2.62
    rCSI 3.58%
    PRS 49.85
  • CD4-positive helper T cell CL0000492
    CSI 2.55
    rCSI 1.93%
    PRS 57.17
  • interneuron CL0000099
    CSI 2.51
    rCSI 5.05%
    PRS 35.03
  • mature astrocyte CL0002627
    CSI 2.51
    rCSI 10.66%
    PRS 42.04
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 2.45
    rCSI 1.63%
    PRS 70.47
  • fibroblast of lung CL0002553
    CSI 2.41
    rCSI 2.24%
    PRS 44.66
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.4
    rCSI 3.3%
    PRS 65.59
  • neural crest cell CL0011012
    CSI 2.39
    rCSI 1.89%
    PRS 32.97
  • activated type II NK T cell CL0000931
    CSI 2.36
    rCSI 2.66%
    PRS 61.31
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.29
    rCSI 2.73%
    PRS 65.27
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 2.28
    rCSI 3.82%
    PRS 29.6
  • regulatory T cell CL0000815
    CSI 2.26
    rCSI 2.62%
    PRS 65.57
  • interstitial cell of Cajal CL0002088
    CSI 2.23
    rCSI 2.84%
    PRS 50.23
  • plasmacytoid dendritic cell, human CL0001058
    CSI 2.22
    rCSI 1.55%
    PRS 46.67
  • peripheral nervous system neuron CL2000032
    CSI 2.19
    rCSI 2.99%
    PRS 38.39
  • early lymphoid progenitor CL0000936
    CSI 2.17
    rCSI 1.91%
    PRS 49.81
  • hematopoietic stem cell CL0000037
    CSI 2.15
    rCSI 1.43%
    PRS 48.64
  • epithelial cell of lung CL0000082
    CSI 2.15
    rCSI 1.78%
    PRS 43.47
  • mature alpha-beta T cell CL0000791
    CSI 2.14
    rCSI 7.75%
    PRS 64
  • mesodermal cell CL0000222
    CSI 2.11
    rCSI 2.54%
    PRS 43.07
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.06
    rCSI 1.39%
    PRS 55.24
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 2.06
    rCSI 5.38%
    PRS 43.97
  • stem cell CL0000034
    CSI 2.05
    rCSI 1.98%
    PRS 35.82
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 1.98
    rCSI 2.8%
    PRS 41.96
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.93
    rCSI 3.3%
    PRS 65.5
  • central nervous system macrophage CL0000878
    CSI 1.92
    rCSI 6.35%
    PRS 46.82
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.91
    rCSI 3.47%
    PRS 38.68
  • cerebral cortex neuron CL0010012
    CSI 1.89
    rCSI 7.72%
    PRS 42.34
  • T-helper 17 cell CL0000899
    CSI 1.88
    rCSI 1.49%
    PRS 66.84
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.84
    rCSI 3.26%
    PRS 28.61
  • B-2 B cell CL0000822
    CSI 0.2
    rCSI 4.2%
    PRS 83.5%
  • direct pathway medium spiny neuron CL4023026
    CSI 0.2
    rCSI 5.2%
    PRS 29.1%
  • pre-conventional dendritic cell CL0002010
    CSI 0.2
    rCSI 3.2%
    PRS 77.6%
  • eye photoreceptor cell CL0000287
    CSI 0.3
    rCSI 3.1%
    PRS 70.0%
  • cone retinal bipolar cell CL0000752
    CSI 0.3
    rCSI 4.1%
    PRS 67.5%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 0.4
    rCSI 0.9%
    PRS 34.6%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.4
    rCSI 2.1%
    PRS 79.5%
  • helper T cell CL0000912
    CSI 0.4
    rCSI 0.6%
    PRS 53.6%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 0.5
    rCSI 1.8%
    PRS 65.3%
  • ON parasol ganglion cell CL4033052
    CSI 0.5
    rCSI 6.5%
    PRS 37.4%
  • cell of skeletal muscle CL0000188
    CSI 0.5
    rCSI 5.2%
    PRS 78.9%
  • indirect pathway medium spiny neuron CL4023029
    CSI 0.5
    rCSI 11.9%
    PRS 29.9%
  • endothelial cell of placenta CL0009092
    CSI 0.5
    rCSI 2.5%
    PRS 56.8%
  • stromal cell of ovary CL0002132
    CSI 0.6
    rCSI 1.6%
    PRS 60.3%
  • cytotoxic T cell CL0000910
    CSI 0.6
    rCSI 3.5%
    PRS 57.0%
  • mesenchymal stem cell CL0000134
    CSI 0.6
    rCSI 7.0%
    PRS 61.3%
  • smooth muscle cell of prostate CL1000487
    CSI 0.7
    rCSI 3.9%
    PRS 70.8%
  • amacrine cell CL0000561
    CSI 0.7
    rCSI 2.0%
    PRS 36.5%
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 0.8
    rCSI 2.5%
    PRS 34.2%
  • dopaminergic neuron CL0000700
    CSI 0.8
    rCSI 4.5%
    PRS 31.7%
  • fibroblast of breast CL4006000
    CSI 0.8
    rCSI 3.5%
    PRS 66.2%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 0.9
    rCSI 5.0%
    PRS 31.0%
  • glycinergic amacrine cell CL4030028
    CSI 0.9
    rCSI 2.3%
    PRS 44.6%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.9
    rCSI 2.8%
    PRS 30.8%
  • myeloid dendritic cell, human CL0001057
    CSI 0.9
    rCSI 5.0%
    PRS 76.2%
  • central nervous system neuron CL2000029
    CSI 0.9
    rCSI 6.6%
    PRS 33.3%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.9
    rCSI 4.5%
    PRS 55.8%
  • germinal center B cell CL0000844
    CSI 0.9
    rCSI 2.7%
    PRS 67.4%
  • stromal cell CL0000499
    CSI 1.0
    rCSI 2.8%
    PRS 44.9%
  • T-helper 1 cell CL0000545
    CSI 1.0
    rCSI 1.8%
    PRS 71.0%
  • myeloid dendritic cell CL0000782
    CSI 1.1
    rCSI 1.5%
    PRS 61.1%
  • retinal ganglion cell CL0000740
    CSI 1.1
    rCSI 2.4%
    PRS 33.6%
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 1.1
    rCSI 2.4%
    PRS 35.6%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 1.1
    rCSI 2.7%
    PRS 63.0%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.1
    rCSI 1.4%
    PRS 29.5%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.2
    rCSI 2.4%
    PRS 62.6%
  • enteric neuron CL0007011
    CSI 1.2
    rCSI 18.1%
    PRS 66.5%
  • lung macrophage CL1001603
    CSI 1.3
    rCSI 2.8%
    PRS 51.4%
  • Langerhans cell CL0000453
    CSI 1.3
    rCSI 1.9%
    PRS 62.1%
  • vascular leptomeningeal cell CL4023051
    CSI 1.3
    rCSI 2.3%
    PRS 37.5%
  • intraepithelial lymphocyte CL0002496
    CSI 1.3
    rCSI 3.6%
    PRS 81.7%
  • sst GABAergic cortical interneuron CL4023017
    CSI 1.3
    rCSI 1.7%
    PRS 30.5%
  • slow muscle cell CL0000189
    CSI 1.4
    rCSI 18.0%
    PRS 68.1%
  • common myeloid progenitor CL0000049
    CSI 1.4
    rCSI 1.1%
    PRS 45.5%
  • retinal rod cell CL0000604
    CSI 1.4
    rCSI 2.4%
    PRS 43.4%
  • group 3 innate lymphoid cell CL0001071
    CSI 1.4
    rCSI 1.1%
    PRS 48.3%
  • M cell of gut CL0000682
    CSI 1.4
    rCSI 1.5%
    PRS 59.8%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 1.5
    rCSI 1.8%
    PRS 40.0%
  • transitional stage B cell CL0000818
    CSI 1.5
    rCSI 4.9%
    PRS 76.7%
  • fallopian tube secretory epithelial cell CL4030006
    CSI 1.5
    rCSI 1.4%
    PRS 45.4%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 1.5
    rCSI 3.7%
    PRS 28.7%
  • mesenchymal cell CL0008019
    CSI 1.5
    rCSI 3.9%
    PRS 40.9%
  • alternatively activated macrophage CL0000890
    CSI 1.6
    rCSI 2.0%
    PRS 58.4%
  • intestinal epithelial cell CL0002563
    CSI 1.6
    rCSI 1.6%
    PRS 44.4%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 1.6
    rCSI 2.1%
    PRS 72.5%
  • common dendritic progenitor CL0001029
    CSI 1.6
    rCSI 2.0%
    PRS 54.6%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 1.6
    rCSI 1.6%
    PRS 58.0%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 1.6
    rCSI 2.0%
    PRS 28.1%
  • B-1 B cell CL0000819
    CSI 1.6
    rCSI 41.7%
    PRS 84.2%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.6
    rCSI 1.4%
    PRS 48.6%
  • serotonergic neuron CL0000850
    CSI 1.7
    rCSI 7.4%
    PRS 31.8%
  • retinal blood vessel endothelial cell CL0002585
    CSI 1.7
    rCSI 2.7%
    PRS 48.7%
  • transit amplifying cell of colon CL0009011
    CSI 1.7
    rCSI 2.0%
    PRS 48.6%
  • fraction A pre-pro B cell CL0002045
    CSI 1.7
    rCSI 1.9%
    PRS 67.5%
  • parietal epithelial cell CL1000452
    CSI 1.7
    rCSI 4.5%
    PRS 38.0%
  • mononuclear phagocyte CL0000113
    CSI 1.7
    rCSI 3.7%
    PRS 48.8%
  • mucous neck cell CL0000651
    CSI 1.7
    rCSI 2.4%
    PRS 58.3%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.7
    rCSI 4.1%
    PRS 41.0%
  • innate lymphoid cell CL0001065
    CSI 1.7
    rCSI 3.6%
    PRS 51.0%
  • acinar cell CL0000622
    CSI 1.8
    rCSI 2.6%
    PRS 56.1%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.8
    rCSI 3.2%
    PRS 35.9%
  • retina horizontal cell CL0000745
    CSI 1.8
    rCSI 2.8%
    PRS 41.6%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.8
    rCSI 3.3%
    PRS 28.6%
  • T-helper 17 cell CL0000899
    CSI 1.9
    rCSI 1.5%
    PRS 66.8%
  • cerebral cortex neuron CL0010012
    CSI 1.9
    rCSI 7.7%
    PRS 42.3%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.9
    rCSI 3.5%
    PRS 38.7%
  • central nervous system macrophage CL0000878
    CSI 1.9
    rCSI 6.4%
    PRS 46.8%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.9
    rCSI 3.3%
    PRS 65.5%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 2.0
    rCSI 2.8%
    PRS 42.0%
  • stem cell CL0000034
    CSI 2.1
    rCSI 2.0%
    PRS 35.8%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 2.1
    rCSI 5.4%
    PRS 44.0%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.1
    rCSI 1.4%
    PRS 55.2%
  • mesodermal cell CL0000222
    CSI 2.1
    rCSI 2.5%
    PRS 43.1%
  • mature alpha-beta T cell CL0000791
    CSI 2.1
    rCSI 7.8%
    PRS 64.0%
  • epithelial cell of lung CL0000082
    CSI 2.2
    rCSI 1.8%
    PRS 43.5%
  • hematopoietic stem cell CL0000037
    CSI 2.2
    rCSI 1.4%
    PRS 48.6%
  • early lymphoid progenitor CL0000936
    CSI 2.2
    rCSI 1.9%
    PRS 49.8%
  • peripheral nervous system neuron CL2000032
    CSI 2.2
    rCSI 3.0%
    PRS 38.4%
  • plasmacytoid dendritic cell, human CL0001058
    CSI 2.2
    rCSI 1.6%
    PRS 46.7%
  • interstitial cell of Cajal CL0002088
    CSI 2.2
    rCSI 2.8%
    PRS 50.2%
  • regulatory T cell CL0000815
    CSI 2.3
    rCSI 2.6%
    PRS 65.6%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 2.3
    rCSI 3.8%
    PRS 29.6%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.3
    rCSI 2.7%
    PRS 65.3%
  • activated type II NK T cell CL0000931
    CSI 2.4
    rCSI 2.7%
    PRS 61.3%
  • neural crest cell CL0011012
    CSI 2.4
    rCSI 1.9%
    PRS 33.0%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.4
    rCSI 3.3%
    PRS 65.6%
  • fibroblast of lung CL0002553
    CSI 2.4
    rCSI 2.2%
    PRS 44.7%
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 2.5
    rCSI 1.6%
    PRS 70.5%
  • mature astrocyte CL0002627
    CSI 2.5
    rCSI 10.7%
    PRS 42.0%
  • interneuron CL0000099
    CSI 2.5
    rCSI 5.1%
    PRS 35.0%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary Bridging integrator 1 ([BIN1](/details-gene/274)) is a multifunctional adaptor protein with well-established roles in membrane dynamics, including [endocytosis](/details-cell/GO:0006897), [cytoskeleton organization](/details-cell/GO:0007010), and vesicle-mediated transport. Encoded by the [BIN1](/details-gene/274) gene on chromosome 2, it is characterized by multiple splice variants that confer tissue-specific functions. Expression data indicates its highest significance in [muscle cell](/details-cell/CL0000187) and [myeloid leukocyte](/details-cell/CL0000766), highlighting its dual importance in muscle physiology and the immune system. Clinically, mutations in [BIN1](/details-gene/274) are linked to autosomal recessive centronuclear myopathy ([255200](https://omim.org/entry/255200)), and genetic variants are significant risk factors for late-onset Alzheimer's disease ([601248](https://omim.org/entry/601248)). The protein also functions as a putative tumor suppressor through its interaction with the Myc oncoprotein, as described in early studies ([Link](https://doi.org/10.1038/ng0996-69)). ## Cellular Roles and Expression Landscape **Overall**, the expression profile of [BIN1](/details-gene/274) reveals its prominent role in distinct cellular lineages, primarily within the muscular, immune, and nervous systems. The gene exhibits its highest significance in the muscular system, with top scores in [muscle cell](/details-cell/CL0000187) (CSI: 25.20), specifically [fast muscle cell](/details-cell/CL0000190) (CSI: 17.84), and [vascular associated smooth muscle cell](/details-cell/CL0000359) (CSI: 10.70). This is consistent with its established function in organizing T-tubules in skeletal muscle, a critical process for excitation-contraction coupling ([Link](https://doi.org/10.1083/jcb.137.6.1355)). Concurrently, [BIN1](/details-gene/274) is a highly significant gene in the immune system. It shows high significance in [myeloid leukocyte](/details-cell/CL0000766) (CSI: 19.83), placental macrophages known as [Hofbauer cell](/details-cell/CL3000001) (CSI: 17.76), and multiple T cell subsets, including [effector memory CD8-positive, alpha-beta T cell](/details-cell/CL0000913) (CSI: 17.49) and [CD4-positive, CD25-positive, alpha-beta regulatory T cell](/details-cell/CL0000792) (CSI: 9.03). Its expression in [CD1c-positive myeloid dendritic cell](/details-cell/CL0002399) and [B cell](/details-cell/CL0000236) further underscores its broad involvement in both innate and adaptive immunity, likely related to its core function in endocytosis which is central to antigen processing and presentation. Finally, significant expression is also noted in specific neuronal populations such as [OFF-bipolar cell](/details-cell/CL0000750) (CSI: 13.86) and [cerebellar granule cell](/details-cell/CL0001031) (CSI: 12.22). This aligns with research identifying neuronal isoforms of [BIN1](/details-gene/274) concentrated at axon initial segments and nerve terminals, implicating it in synaptic vesicle recycling ([Link](https://doi.org/10.1074/jbc.272.26.16700)). ## Pathways and Molecular Function The molecular functions of [BIN1](/details-gene/274) are deeply rooted in membrane trafficking and cytoskeletal interaction. Its involvement in pathways such as [Clathrin-mediated endocytosis](/details-pathway/R-HSA-8856828) and the broader processes of [Membrane trafficking](/details-pathway/R-HSA-199991) and [Vesicle-mediated transport](/details-pathway/R-HSA-5653656) provides a mechanistic basis for its diverse cellular roles. Gene Ontology annotations reveal its role as a key player in [endocytosis](/details-cell/GO:0006897), particularly [synaptic vesicle endocytosis](/details-cell/GO:0048488) in neurons. This is mediated by its molecular ability to bind key components of this machinery, including [clathrin binding](/details-cell/GO:0030276) ([Link](https://doi.org/10.1046/j.1471-4159.1998.70062369.x)), [GTPase binding](/details-cell/GO:0051020) (e.g., dynamin), and [phospholipid binding](/details-cell/GO:0005543) to sense and induce membrane curvature. Its role in muscle is directly supported by its function in [T-tubule organization](/details-cell/GO:0033292) and its localization to the [Z disc](/details-cell/GO:0030018) and [I band](/details-cell/GO:0031674). Furthermore, [BIN1](/details-gene/274) acts as a signaling adaptor protein, evidenced by its numerous protein-protein interaction domains and binding activities, including [actin filament binding](/details-cell/GO:0051015) and [tau protein binding](/details-cell/GO:0048156). The latter is particularly relevant to its association with Alzheimer's disease, where it may influence tau pathology. The protein also has roles in nuclear processes, including [negative regulation of transcription by rna polymerase ii](/details-cell/GO:0000122), consistent with its identification as a Myc-interacting tumor suppressor ([Link](https://doi.org/10.1038/ng0996-69)). ## Research Directions The diverse, tissue-specific roles of [BIN1](/details-gene/274) present multiple avenues for future investigation, particularly concerning its contribution to complex diseases. **Proposed Hypotheses:** 1. Given its high significance in [myeloid leukocyte](/details-cell/CL0000766) and its core function in endocytosis, [BIN1](/details-gene/274) likely modulates antigen uptake and processing in dendritic cells and macrophages. We hypothesize that myeloid-specific isoforms of [BIN1](/details-gene/274) are critical for the efficiency of MHC class II pathway antigen presentation, and their dysregulation could contribute to inflammatory disorders. 2. Building on the established genetic link to Alzheimer's disease ([601248](https://omim.org/entry/601248)) and its annotated function in [tau protein binding](/details-cell/GO:0048156), we hypothesize that disease-associated risk variants of [BIN1](/details-gene/274) alter its interaction with tau, thereby impairing the endocytic clearance of pathological tau species and facilitating their cell-to-cell propagation in the brain. 3. Based on its causal role in centronuclear myopathy ([255200](https://omim.org/entry/255200)) and its high expression in [muscle cell](/details-cell/CL0000187), we hypothesize that disease-causing mutations disrupt the scaffolding function of [BIN1](/details-gene/274) at the T-tubule, specifically its interaction with dynamin 2 ([Link](https://doi.org/10.1038/ng2086)), leading to defective membrane remodeling and impaired excitation-contraction coupling. **Experimental Approach:** To test the hypothesis regarding Alzheimer's disease (Hypothesis 2), one could utilize an iPSC-derived neuron model. Neurons would be generated from individuals carrying high-risk [BIN1](/details-gene/274) variants and from healthy, non-carrier controls. CRISPR-Cas9-mediated knockout or correction of the risk allele would serve as isogenic controls. These neuronal cultures would be exposed to exogenous, fluorescently-tagged, aggregation-prone tau seeds. The role of [BIN1](/details-gene/274) in tau trafficking would be assessed by quantifying the rate of tau uptake, its subcellular localization via confocal microscopy, and its subsequent secretion into the media using sensitive immunoassays (ELISA). This would directly test whether disease-associated variants impair the cellular handling of pathogenic tau. **Therapeutic Potential:** The therapeutic potential of targeting [BIN1](/details-gene/274) is highly context-dependent. As a putative tumor suppressor, general inhibition is likely contraindicated in oncology. For centronuclear myopathy, which is a recessive loss-of-function disorder, AAV-mediated gene replacement therapy aimed at restoring [BIN1](/details-gene/274) expression in muscle tissue is a direct and promising therapeutic strategy. In Alzheimer's disease, the approach is more complex; if risk variants lead to a loss-of-function in tau clearance, therapeutic strategies could focus on enhancing the activity of specific neuronal [BIN1](/details-gene/274) isoforms or downstream pathways to restore normal endocytic function.

Genular Protein ID: 3599018716

Symbol: BIN1_HUMAN

Name: Myc box-dependent-interacting protein 1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9195986

Title: Identification and characterization of a nerve terminal-enriched amphiphysin isoform.

PubMed ID: 9195986

DOI: 10.1074/jbc.272.26.16700

PubMed ID: 9182667

Title: Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of Ranvier in brain and around T tubules in skeletal muscle.

PubMed ID: 9182667

DOI: 10.1083/jcb.137.6.1355

PubMed ID: 8782822

Title: BIN1 is a novel Myc-interacting protein with features of a tumour suppressor.

PubMed ID: 8782822

DOI: 10.1038/ng0996-69

PubMed ID: 9603201

Title: Multiple amphiphysin II splice variants display differential clathrin binding: identification of two distinct clathrin-binding sites.

PubMed ID: 9603201

DOI: 10.1046/j.1471-4159.1998.70062369.x

PubMed ID: 9223448

Title: cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants.

PubMed ID: 9223448

DOI: 10.1006/bbrc.1997.6927

PubMed ID: 9395479

Title: Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.

PubMed ID: 9395479

DOI: 10.1074/jbc.272.50.31453

PubMed ID: 17974005

Title: The full-ORF clone resource of the German cDNA consortium.

PubMed ID: 17974005

DOI: 10.1186/1471-2164-8-399

PubMed ID: 15815621

Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PubMed ID: 15815621

DOI: 10.1038/nature03466

PubMed ID: 9418903

Title: A role for the putative tumor suppressor Bin1 in muscle cell differentiation.

PubMed ID: 9418903

DOI: 10.1128/mcb.18.1.566

PubMed ID: 10903846

Title: Bin2, a functionally nonredundant member of the BAR adaptor gene family.

PubMed ID: 10903846

DOI: 10.1006/geno.2000.6216

PubMed ID: 12668730

Title: Sorting nexin 4 and amphiphysin 2, a new partnership between endocytosis and intracellular trafficking.

PubMed ID: 12668730

DOI: 10.1242/jcs.00403

PubMed ID: 17081983

Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

PubMed ID: 17081983

DOI: 10.1016/j.cell.2006.09.026

PubMed ID: 16530520

Title: The SH3 binding motif of HCV NS5A protein interacts with Bin1 and is important for apoptosis and infectivity.

PubMed ID: 16530520

DOI: 10.1053/j.gastro.2005.12.030

PubMed ID: 17676042

Title: Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.

PubMed ID: 17676042

DOI: 10.1038/ng2086

PubMed ID: 19367720

Title: Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.

PubMed ID: 19367720

DOI: 10.1021/pr800500r

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24755653

Title: Mutations in BIN1 associated with centronuclear myopathy disrupt membrane remodeling by affecting protein density and oligomerization.

PubMed ID: 24755653

DOI: 10.1371/journal.pone.0093060

PubMed ID: 27179792

Title: BIN1 regulates BACE1 intracellular trafficking and amyloid-beta production.

PubMed ID: 27179792

DOI: 10.1093/hmg/ddw146

PubMed ID: 27488240

Title: Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.

PubMed ID: 27488240

DOI: 10.1186/s13024-016-0124-1

PubMed ID: 28893863

Title: Bin1 directly remodels actin dynamics through its BAR domain.

PubMed ID: 28893863

DOI: 10.15252/embr.201744137

PubMed ID: 20142620

Title: Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation.

PubMed ID: 20142620

DOI: 10.1212/wnl.0b013e3181cef7f9

PubMed ID: 25260562

Title: Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.

PubMed ID: 25260562

DOI: 10.1093/brain/awu272

PubMed ID: 29950440

Title: A Roma founder BIN1 mutation causes a novel phenotype of centronuclear myopathy with rigid spine.

PubMed ID: 29950440

DOI: 10.1212/wnl.0000000000005862

Sequence Information:

  • Length: 593
  • Mass: 64699
  • Checksum: 0FF1956F0C7E3B50
  • Sequence:
  • MAEMGSKGVT AGKIASNVQK KLTRAQEKVL QKLGKADETK DEQFEQCVQN FNKQLTEGTR 
    LQKDLRTYLA SVKAMHEASK KLNECLQEVY EPDWPGRDEA NKIAENNDLL WMDYHQKLVD 
    QALLTMDTYL GQFPDIKSRI AKRGRKLVDY DSARHHYESL QTAKKKDEAK IAKPVSLLEK 
    AAPQWCQGKL QAHLVAQTNL LRNQAEEELI KAQKVFEEMN VDLQEELPSL WNSRVGFYVN 
    TFQSIAGLEE NFHKEMSKLN QNLNDVLVGL EKQHGSNTFT VKAQPSDNAP AKGNKSPSPP 
    DGSPAATPEI RVNHEPEPAG GATPGATLPK SPSQLRKGPP VPPPPKHTPS KEVKQEQILS 
    LFEDTFVPEI SVTTPSQFEA PGPFSEQASL LDLDFDPLPP VTSPVKAPTP SGQSIPWDLW 
    EPTESPAGSL PSGEPSAAEG TFAVSWPSQT AEPGPAQPAE ASEVAGGTQP AAGAQEPGET 
    AASEAASSSL PAVVVETFPA TVNGTVEGGS GAGRLDLPPG FMFKVQAQHD YTATDTDELQ 
    LKAGDVVLVI PFQNPEEQDE GWLMGVKESD WNQHKELEKC RGVFPENFTE RVP

Genular Protein ID: 2427542689

Symbol: Q9BTH3_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

Sequence Information:

  • Length: 439
  • Mass: 48286
  • Checksum: 350E428C8E198136
  • Sequence:
  • MAEMGSKGVT AGKIASNVQK KLTRAQEKVL QKLGKADETK DEQFEQCVQN FNKQLTEGTR 
    LQKDLRTYLA SVKAMHEASK KLNECLQEVY EPDWPGRDEA NKIAENNDLL WMDYHQKLVD 
    QALLTMDTYL GQFPDIKSRI AKRGRKLVDY DSARHHYESL QTAKKKDEAK IAKAEEELIK 
    AQKVFEEMNV DLQEELPSLW NSRVGFYVNT FQSIAGLEEN FHKEMSKLNQ NLNDVLVGLE 
    KQHGSNTFTV KAQPSDNAPA KGNKSPSPPD GSPAATPEIR VNHEPEPAGG ATPGATLPKS 
    PSQPAEASEV AGGTQPAAGA QEPGETAASE AASSSLPAVV VETFPATVNG TVEGGSGAGR 
    LDLPPGFMFK VQAQHDYTAT DTDELQLRAG DVVLVIPFQN PEEQDEGWLM GVKESDWNQH 
    KELEKCRGVF PENFTERVP

Genular Protein ID: 3497018245

Symbol: B7Z2Z2_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 470
  • Mass: 51711
  • Checksum: DC211F88681AC56B
  • Sequence:
  • MAEMGSKGVT AGKIASNVQK KLTRAQEKVL QKLGKADETK DEQFEQCVQN FNKQLTEGTR 
    LQKDLRTYLA SVKAMHEASK KLNECLQEVY EPDWPGRDEA NKIAENNDLL WMDYHQKLVD 
    QALLTMDTYL GQFPDIKSRI AKRGRKLVDY DSARHHYESL QTAKKKDEAK IAKPVSLLEK 
    AAPQWCQGKL QAHLVAQTNL LRNQAEEELI KAQKVFEEMN VDLQEELPSL WNSRVGFYVN 
    TFQSIAGLEE NFHKEMSKLN QNLNDVLVGL EKQHGSNTFT VKAQPSDNAR AKGNKSPSPP 
    DGSPAATPEI RVNHEPEPAG GATPGATLPK SPSQPAEASE VAGGTQPAAG AQEPGETAAS 
    EAASSSLPAV VVETFPATVN GTVEGGSGAG RLDLPPGFMF KVQAQHDYTA TDTDELQLRA 
    GDVVLVIPFQ NPEEQDEGWL MGVKESDWNQ HKELEKCRGV FPENFTGRVP

Genular Protein ID: 3353487358

Symbol: B7Z6Y2_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 385
  • Mass: 43165
  • Checksum: 291A5612A0829A4A
  • Sequence:
  • MMRKVLQKLG KADETKDEQF EQCVQNFNKQ LTEGTRLQKD LRTYLASVKA MHEASKKLNE 
    CLQEVYEPDW PGRDEANKIA ENNDLLWMDY HQKLVDQALL TMDTYLGQFP DIKSRIAKRG 
    RKLVDYDSAR HHYESLQTAK KKDEAKIAKA EEELIKAQKV FEEMNVDLQE ELPSLWNSRV 
    GFYVNTFQSI AGLEENFHKE MSKLNQNLND VLVGLEKQHG SNTFTVKAQP SDNAPAKGNK 
    SPSPPDGSPA ATPEIRVNHE PEPAGGATPG ATLPKSPSQS SLPAVVVETF PATVNGTVEG 
    GSGAGRLDLP PGFMFKVQAQ HDYTATDTDE LQLKAGDVVL VIPFQNPEEQ DEGWLMGVKE 
    SDWNQHKELE KCRGVFPENF TERVP